Literature DB >> 35389061

[Multiparametric MRI of the prostate].

Judith Herrmann1, Sascha Kaufmann2, Cecilia Zhang1, Steffen Rausch3, Jens Bedke3, Arnulf Stenzl3, Konstantin Nikolaou1, Stephan Kruck4, Ferdinand Seith1.   

Abstract

Multiparametric magnetic resonance imaging (mpMRI) is an integral component of prostate cancer diagnostics. According to the S3 guidelines on prostate cancer, mpMRI should be used for the primary diagnostics of prostate cancer as well as in active surveillance (AS). Basically, mpMRI consists of high-resolution T2-weighted (T2w) sequences, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) sequences, which in turn are the basis for structured reporting according to the prostate imaging reporting and data system (PI-RADS) classification.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Appraisal; Diagnostic imaging; Guideline; PI-RADS; Prostatic neoplasms

Mesh：

Year:  2022        PMID： 35389061     DOI： 10.1007/s00120-022-01806-7

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  2 in total

1.  mpMRI of the Prostate (MR-Prostatography): Updated Recommendations of the DRG and BDR on Patient Preparation and Scanning Protocol.

Authors:  Tobias Franiel; Patrick Asbach; Dirk Beyersdorff; Dirk Blondin; Sascha Kaufmann; Ullrich Gerd Mueller-Lisse; Michael Quentin; Stefan Rödel; Matthias Röthke; Heinz-Peter Schlemmer; Lars Schimmöller
Journal:  Rofo       Date:  2021-03-18

Review 2.  MRI of the Prostate: Recommendations on Patient Preparation and Scanning Protocol.

Authors:  Tobias Franiel; Michael Quentin; Ullrich Gerd Mueller-Lisse; Lars Schimmoeller; Patrick Asbach; Stefan Rödel; Winfried Willinek; Katja Hueper; Dirk Beyersdorff; Matthias Röthke
Journal:  Rofo       Date:  2016-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.